Ghent University Academic Bibliography

Mark

Angiopoietin-2 promotes pathological angiogenesis and is a novel therapeutic target in murine non-alcoholic fatty liver disease

Sander Lefere (UGent) , Frederique Van de Velde (UGent) , Anne Hoorens (UGent) , Sarah Raevens (UGent) , Sanne Van Campenhout (UGent) , Astrid Vandierendonck (UGent) , Sara Neyt (UGent) , Bert Vandeghinste (UGent) , Christian Vanhove (UGent) , Charlotte Debbaut (UGent) , et al.

(2019) HEPATOLOGY.

Mark

Hepatic changes in the fontan circulation : identification of liver dysfunction and an attempt to streamline follow-up screening

Thomas Ackerman (UGent) , Anja Geerts (UGent) , Hans Van Vlierberghe (UGent) , Julie De Backer (UGent) and Kato François (UGent)

(2018) PEDIATRIC CARDIOLOGY. 39(8). p.1604-1613

Mark

conference

Cu isotope ratio shifts in common bile duct ligated mice and correlates with the degree of cholestatic-induced liver disease

Sanne Van Campenhout (UGent) , Marta Costas Rodriguez (UGent) , Agustina Ari Murti Budi Hastuti (UGent) , Sarah Raevens (UGent) , Anja Geerts (UGent) , Xavier Verhelst (UGent) , Frank Vanhaecke (UGent) , Hans Van Vlierberghe (UGent) and Lindsey Devisscher (UGent)

(2018) In Journal of Hepatology 68.

Mark

conference

Angiopoietin‐2 Promotes Pathological Angiogenesis and Is a Novel Therapeutic Target in Non‐Alcoholic Fatty Liver Disease

Sander Lefere (UGent) , Frederique Van de Velde (UGent) , Anne Hoorens (UGent) , Sarah Raevens (UGent) , Sanne Van Campenhout (UGent) , Astrid Vandierendonck (UGent) , Sara Neyt (UGent) , Bert Vandeghinste (UGent) , Christian Vanhove (UGent) , Charlotte Debbaut (UGent) , et al.

(2018) In Hepatology 68(S1). p.753A-753A

Mark

Placental growth factor inhibition targets pulmonary angiogenesis and represents a novel therapy for hepatopulmonary syndrome in mice

Sarah Raevens (UGent) , Anja Geerts (UGent) , Annelies Paridaens (UGent) , Sander Lefere (UGent) , Xavier Verhelst (UGent) , Anne Hoorens (UGent) , Jo Van Dorpe (UGent) , Tania Maes (UGent) , Ken Bracke (UGent) , Christophe Casteleyn (UGent) , et al.

(2018) HEPATOLOGY. 68(2). p.634-651

Mark

Glycome patterns of perfusate in livers before transplantation associate with primary non-function

Xavier Verhelst (UGent) , Anja Geerts (UGent) , Ina Jochmans, Dieter Vanderschaeghe (UGent) , Agnes Paradissis (UGent) , Aude Vanlander (UGent) , Frederik Berrevoet (UGent) , Géraldine Dahlqvuist, Frederik Nevens, Jacques Pirenne, et al.

(2018) GASTROENTEROLOGY. 154(5). p.1361-1368

Mark

Clinical burden of hepatitis E virus infection in a tertiary care center in Flanders, Belgium

Lien Cattoir (UGent) , FREDERIK VAN HOECKE (UGent) , Tom Van Maerken (UGent) , Eline Nys, Inge Ryckaert (UGent) , Matthias De Boulle (UGent) , Anja Geerts (UGent) , Xavier Verhelst (UGent) , Isabelle Colle (UGent) , Veronik Hutse, et al.

(2018) JOURNAL OF CLINICAL VIROLOGY. 103. p.8-11

Mark

journalArticle

Angiopoietin-2 promotes pathological angiogenesis and is a novel therapeutic target in murine non-alcoholic fatty liver disease

Sander Lefere (UGent) , Frederique Van de Velde (UGent) , Anne Hoorens (UGent) , Sarah Raevens (UGent) , Sanne Van Campenhout (UGent) , Astrid Vandierendonck (UGent) , Sara Neyt (UGent) , Bert Vandeghinste (UGent) , Christian Vanhove (UGent) , Charlotte Debbaut (UGent) , et al.

(2018) Hepatology.

Mark

Model for end-stage liver disease score and hemodynamic instability as a predictor of poor outcome in early transjugular intrahepatic portosystemic shunt treatment for acute variceal hemorrhage

Laurens Hermie (UGent) , Elisabeth Dhondt (UGent) , Peter Vanlangenhove (UGent) , Eric Hoste (UGent) , Anja Geerts (UGent) and Luc Defreyne (UGent)

(2018) EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY. 30(12). p.1441-1446

Mark

Pretransplant glycomic analysis of perfusate is predictive of primary non function after liver transplantation

Xavier Verhelst (UGent) , Anja Geerts (UGent) , Dieter Vanderschaeghe (UGent) , Xavier Rogiers (UGent) , Aude Vanlander (UGent) , Frederik Berrevoet (UGent) , Nico Callewaert (UGent) , Roberto Troisi (UGent) and Hans Van Vlierberghe (UGent)

(2017) JOURNAL OF HEPATOLOGY. 66(1, suppl.). p.S201-S201

Academic Bibliography

Angiopoietin-2 promotes pathological angiogenesis and is a novel therapeutic target in murine non-alcoholic fatty liver disease

Hepatic changes in the fontan circulation : identification of liver dysfunction and an attempt to streamline follow-up screening

Cu isotope ratio shifts in common bile duct ligated mice and correlates with the degree of cholestatic-induced liver disease

Angiopoietin‐2 Promotes Pathological Angiogenesis and Is a Novel Therapeutic Target in Non‐Alcoholic Fatty Liver Disease

Placental growth factor inhibition targets pulmonary angiogenesis and represents a novel therapy for hepatopulmonary syndrome in mice

Glycome patterns of perfusate in livers before transplantation associate with primary non-function

Clinical burden of hepatitis E virus infection in a tertiary care center in Flanders, Belgium

Angiopoietin-2 promotes pathological angiogenesis and is a novel therapeutic target in murine non-alcoholic fatty liver disease

Model for end-stage liver disease score and hemodynamic instability as a predictor of poor outcome in early transjugular intrahepatic portosystemic shunt treatment for acute variceal hemorrhage

Pretransplant glycomic analysis of perfusate is predictive of primary non function after liver transplantation

Contents

Support

Contact